Cargando…
An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia
This study aimed to assess the efficacy and tolerability of atorvastatin in Tanner stage (TS) 1 patients ages 6 to 10 years and TS ≥2 patients ages 10 to <18 years with genetically confirmed heterozygous familial hypercholesterolemia (HeFH) and a low density lipoprotein cholesterol (LDL-C) level...
Autores principales: | Gandelman, Kuan, Glue, Paul, Laskey, Rachel, Jones, Jonathan, LaBadie, Robert, Ose, Leiv |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061213/ https://www.ncbi.nlm.nih.gov/pubmed/21259004 http://dx.doi.org/10.1007/s00246-011-9885-z |
Ejemplares similares
-
Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
por: McGowan, Mary P., et al.
Publicado: (2019) -
Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study
por: Feng, Xiaomeng, et al.
Publicado: (2017) -
Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010) -
Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia
por: Senthilvel, Chitra Karthikeyini, et al.
Publicado: (2022) -
Safety of atorvastatin in Asian patients within clinical trials
por: Chan, Juliana C. N., et al.
Publicado: (2016)